Evidence map›Paper›PMID 20426618›Full record

ArticleRejuvenation research2010

Trade-offs between cancer and other diseases: do they exist and influence longevity?

Svetlana V Ukraintseva, Konstantin G Arbeev, Igor Akushevich, Alexander Kulminski, Liubov Arbeeva, Irina Culminskaya, Lucy Akushevich, Anatoli I Yashin

Open access · greenAbstract read
In one paragraph

Article in Rejuvenation research, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Cancer and aging: Epidemiology and methodological challenges.Acta oncologica (Stockholm, Sweden) · 2016
    Article
  11. Article
  12. Gene expression signatures of human cell and tissue longevity.NPJ aging and mechanisms of disease · 2016
    Article
  13. Article
  14. The multiple facets of Peto's paradox: a life-history model for the evolution of cancer suppression.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2015
    Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Cancer and longevity--is there a trade-off? A study of cooccurrence in Danish twin pairs born 1900-1918.The journals of gerontology. Series A, Biological sciences and medical sciences · 2012
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Svetlana V UkraintsevaCenter for Population Health and Aging, Duke University, Durham, North Carolina 27708, USA. svo@duke.edu
Konstantin G Arbeev
Igor Akushevich
Alexander Kulminski
Liubov Arbeeva
Irina Culminskaya
Lucy Akushevich
Anatoli I Yashin
Duke University · US

Funding

EVALUATING NEW GENETIC EFFECTS ON HEALTH AND AGING FROM LONGITUDINAL DATAR01AG030612 · NIA · DUKE UNIVERSITY · PI YASHIN, ANATOLIY I · 2007 to 2011
$2.9M
Healthy Life at Risk: The Role of SenescenceR01AG028259 · NIA · DUKE UNIVERSITY · PI YASHIN, ANATOLIY I · 2005 to 2009
$1.2M
The future of major geriatric disorders in the US elderlyR01AG032319 · NIA · DUKE UNIVERSITY · PI YASHIN, ANATOLIY I · 2008 to 2012
$1.1M
NIA NIH HHS R01AG028259NIA NIH HHS R01 AG030612NIA NIH HHS R01AG032319
6 · The paper itself

Abstract

Relationships between aging, disease risks, and longevity are not yet well understood. For example, joint increases in cancer risk and total survival observed in many human populations and some experimental aging studies may be linked to a trade-off between cancer and aging as well as to the trade-off(s) between cancer and other diseases, and their relative impact is not clear. While the former trade-off (between cancer and aging) received broad attention in aging research, the latter one lacks respective studies, although its understanding is important for developing optimal strategies of increasing both longevity and healthy life span. In this paper, we explore the possibility of trade-offs between risks of cancer and selected major disorders. First, we review current literature suggesting that the trade-offs between cancer and other diseases may exist and be linked to the differential intensity of apoptosis. Then we select relevant disorders for the analysis (acute coronary heart disease [ACHD], stroke, asthma, and Alzheimer disease [AD]) and calculate the risk of cancer among individuals with each of these disorders, and vice versa, using the Framingham Study (5209 individuals) and the National Long Term Care Survey (NLTCS) (38,214 individuals) data. We found a reduction in cancer risk among old (80+) men with stroke and in risk of ACHD among men (50+) with cancer in the Framingham Study. We also found an increase in ACHD and stroke among individuals with cancer, and a reduction in cancer risk among women with AD in the NLTCS. The manifestation of trade-offs between risks of cancer and other diseases thus depended on sex, age, and study population. We discuss factors modulating the potential trade-offs between major disorders in populations, e.g., disease treatments. Further study is needed to clarify possible impact of such trade-offs on longevity.

Indexed as

DiseaseLongevityAdultFemaleHumansMaleMiddle AgedNeoplasms

Identifiers

PMID20426618
PMCPMC2959185
OpenAlexW2024607021

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.